Hollencrest Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Hollencrest Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75	Closed	-$10.8K	–	1206
2025 Q3	$10.8K	Hold	75	–	–	﹤0.01%	787
2025 Q2	$9.49K	Hold	75	–	–	﹤0.01%	776
2025 Q1	$9.59K	Hold	75	–	–	﹤0.01%	784
2024 Q4	$9.92K	Hold	75	–	–	﹤0.01%	796
2024 Q3	$10.9K	Sell	75 -75	-50%	-$10.9K	﹤0.01%	744
2024 Q2	$20.6K	Buy	150 +75	+100%	+$10K	﹤0.01%	666
2024 Q1	$10.3K	Hold	75	–	–	﹤0.01%	715
2023 Q4	$10.2K	Hold	75	–	–	﹤0.01%	722
2023 Q3	$9.17K	Hold	75	–	–	﹤0.01%	741
2023 Q2	$9.52K	Hold	75	–	–	﹤0.01%	761
2023 Q1	$9.69K	Hold	75	–	–	﹤0.01%	749
2022 Q4	$9.85K	Buy	+75	New	+$9.69K	﹤0.01%	728

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Hollencrest Capital Management's IBB Position: Q4 2025 in Review

Hollencrest Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 75 shares — an estimated $10.8K sold.

Hollencrest Capital Management first reported a position in IBB in Q4 2022 and held it in 12 quarters. The position peaked at $20.6K in Q2 2024. 957 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Hollencrest Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Hollencrest Capital Management sold 75 iShares Biotechnology ETF shares in Q4 2025, an estimated $10.8K.
Hollencrest Capital Management first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 12 quarters.
Hollencrest Capital Management's iShares Biotechnology ETF position peaked at $20.6K in Q2 2024.
957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Hollencrest Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.